🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Adult acute lymphoblastic leukemia (ALL) includes Ph-positive (Phpos) ALL, ...
Status
Recruiting
Location
Hôpital Saint Louis
Start Date
2025-05-06
Trial ID
NCT06860269
Treatments Being Tested
This is a randomised, open-label, multicenter, phase III study for adult de...
Status
Active Not Recruiting
Location
Area Vasta N. 5 Ascoli Piceno - S. Benedetto Del Tronto, Presidio Ospedaliero Av5 Osp. Gen. Prov.Le "C.G.Mazzoni" - Uoc Ematologia
Start Date
2021-09-08
Trial ID
NCT04722848
Treatments Being Tested
The purpose of this research study is to see if a drug called LP-118 is saf...
Status
Not Yet Recruiting
Location
Atrium Health Levine Cancer
Start Date
2026-10
Trial ID
NCT07614022
Treatments Being Tested
This phase III trial compares the effect of usual treatment of chemotherapy...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2021-01-25
Trial ID
NCT04530565
Treatments Being Tested
This phase II trial studies how well low-intensity chemotherapy and ponatin...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2018-02-08
Trial ID
NCT03147612
This phase II trial studies how well blinatumomab, methotrexate, cytarabine...
Status
Recruiting
Location
M D Anderson Cancer Center
Start Date
2017-11-29
Trial ID
NCT03263572
Treatments Being Tested
An Open Label, 3-arm, Randomised Phase II Study to Compare the Safety and E...
Status
Unknown
Location
Multiple Locations
Start Date
2021-01
Trial ID
NCT04688983
Treatments Being Tested
B-cell acute lymphoblastic leukemia (B-ALL) is an aggressive blood cancer; ...
Status
Not Yet Recruiting
Location
University of Alberta
Start Date
2027-01-02
Trial ID
NCT07301424
Treatments Being Tested
This phase II trial studies how well inotuzumab ozogamicin and blinatumomab...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2019-05-08
Trial ID
NCT03739814
The current Standard of Care (SoC) in younger patients with Ph+ ALL is Imat...
Status
Recruiting
Location
Uniklinik RWTH Aachen
Start Date
2023-07-14
Trial ID
NCT06061094
Treatments Being Tested